Biotech Firm Announces ‘Pivotal Step’ in Effort to Bring Back the Dodo
Colossal Biosciences raised $120 million, extending its Series C to $320 million and valuing the company at $10.3 billion to advance dodo bird de-extinction.
- Colossal Biosciences announced on September 17 that its scientists successfully grew pigeon primordial germ cells, a key step toward dodo revival in Texas.
- The achievement follows the company's 2021 founding and aims to use gene-edited surrogates like chickens to breed dodos, with critics noting limits to true resurrection.
- The company plans to inject edited cells from the Nicobar pigeon, the dodo's closest relative, into surrogate chickens and also targets the extinct moa bird.
- Colossal has raised $120 million more in funding, boosting its valuation past $10.3 billion, with CEO Ben Lamm describing the team's achievement as a major step forward for efforts to bring back the dodo.
- This progress supports plans for dodo rewilding in Mauritius, while the firm’s broader goals include advancing avian conservation and accelerating de-extinction projects.
62 Articles
62 Articles
Scientists Take First Step to Revive the Extinct Dodo Bird After 300 Years
Biotech firm Colossal Biosciences, famed for its controversial de-extinction projects, says it has achieved a breakthrough in efforts to revive the long-lost dodo bird. Five months after claiming to bring back the dire wolf, the Texas-based company revealed its researchers have successfully grown pigeon primordial germ cells, a key step in gene editing toward resurrecting the bird that vanished from Mauritius more than three centuries ago. Yet A…
Scientists edge closer to resurrecting extinct dodo bird - by using pigeon DNA
The dodo is one step closer to being resurrected thanks to a remarkable new genetic engineering experiment.Scientists have genetically "edited" chickens - which they could lay eggs containing the extinct bird.Colossal Biosciences, which just weeks ago announced plans to revive the long-dead giant Moa, is behind the breakthrough.The firm, a biotechnology and genetic engineering company in Texas, has managed to create chickens which do not have th…
Coverage Details
Bias Distribution
- 78% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
